XMARK ASSET MANAGEMENT LLC

Insider profile

XMARK ASSET MANAGEMENT LLC's trades of Antares Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
234.75
Quantity 74,352 +4.0%
Value US$2,375,564
Transaction date
Sale
Price
425.91
Quantity 16,304 -25.9%
Value US$1,754,253
Transaction date
Sale
Price
182.12
Quantity 23,901 +35.4%
Value US$3,223,935
Transaction date
Sale
Price
1.00
Quantity 492,500 -16.5%
Value US$492,500
Transaction date
Sale
Price
1.00
Quantity 50,000 -1.6%
Value US$50,000
Transaction date
Sale
Price
1.00
Quantity 210,000 -6.5%
Value US$210,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2004-05-25 2004-05-24
S Sale
74,352 +4.0%
234.75
US$2,375,564 		74,352 +4.0% 234.75 US$2,375,564
2004-05-20 2004-05-19
S Sale
16,304 -25.9%
425.91
US$1,754,253 		16,304 -25.9% 425.91 US$1,754,253
2004-05-19 2004-05-17
S Sale
23,901 +35.4%
182.12
US$3,223,935 		23,901 +35.4% 182.12 US$3,223,935
2004-05-17 2004-05-14
S Sale
492,500 -16.5%
1.00
US$492,500 		492,500 -16.5% 1.00 US$492,500
2004-05-17 2004-05-13
S Sale
50,000 -1.6%
1.00
US$50,000 		50,000 -1.6% 1.00 US$50,000
2004-05-13 2004-05-13
S Sale
210,000 -6.5%
1.00
US$210,000 		210,000 -6.5% 1.00 US$210,000